Suppr超能文献

麻风病中γ干扰素产生缺陷。抗原和白细胞介素2可使其恢复。

Defective gamma interferon production in leprosy. Reversal with antigen and interleukin 2.

作者信息

Nogueira N, Kaplan G, Levy E, Sarno E N, Kushner P, Granelli-Piperno A, Vieira L, Colomer Gould V, Levis W, Steinman R

出版信息

J Exp Med. 1983 Dec 1;158(6):2165-70. doi: 10.1084/jem.158.6.2165.

DOI:10.1084/jem.158.6.2165
PMID:6417263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2187179/
Abstract

Antigen and mitogen-induced gamma interferon (gamma-IFN) production was studied in peripheral blood mononuclear cells from 34 leprosy patients. 17 of 18 lepromatous leprosy and borderline lepromatous patients (LL and BL) failed to release gamma-IFN in response to specific antigen (Mycobacterium leprae) and displayed reduced responses to mitogen (concanavalin A) stimulation. In contrast, cells from six tuberculoid and borderline tuberculoid patients (TT and BT) produced considerable levels of gamma-IFN under the same experimental conditions. Normal controls failed to respond to M. leprae and most displayed good responses to concanavalin A. Mid-borderline patients (BB) showed intermediate levels of gamma-IFN release. gamma-IFN release by lepromatous patients could be partially restored with purified interleukin 2 and M. leprae antigen but not with interleukin 2 alone.

摘要

对34例麻风病患者外周血单个核细胞中抗原和丝裂原诱导的γ干扰素（γ-IFN）产生情况进行了研究。18例瘤型麻风及界线类偏瘤型患者（LL和BL）中有17例对特异性抗原（麻风分枝杆菌）无γ-IFN释放反应，对丝裂原（刀豆球蛋白A）刺激的反应也降低。相比之下，6例结核样型和界线类偏结核样型患者（TT和BT）的细胞在相同实验条件下产生了相当水平的γ-IFN。正常对照对麻风分枝杆菌无反应，大多数对刀豆球蛋白A反应良好。中间界线类患者（BB）的γ-IFN释放水平处于中间状态。瘤型患者的γ-IFN释放可通过纯化的白细胞介素2和麻风分枝杆菌抗原部分恢复，但单独使用白细胞介素2则不能。

相似文献

1
Defective gamma interferon production in leprosy. Reversal with antigen and interleukin 2.
J Exp Med. 1983 Dec 1;158(6):2165-70. doi: 10.1084/jem.158.6.2165.
2
Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
Int J Lepr Other Mycobact Dis. 1993 Mar;61(1):51-8.
3
Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
J Immunol. 1993 May 15;150(10):4641-51.
4
An analysis of in vitro T cell responsiveness in lepromatous leprosy.
J Exp Med. 1985 Sep 1;162(3):917-29. doi: 10.1084/jem.162.3.917.
5
Immunogenicity of Mycobacterium leprae unique antigens in leprosy endemic populations in Asia and Africa.
Lepr Rev. 2011 Dec;82(4):445-58.
6
Signaling lymphocytic activation molecule expression and regulation in human intracellular infection correlate with Th1 cytokine patterns.
J Immunol. 2001 Nov 15;167(10):5719-24. doi: 10.4049/jimmunol.167.10.5719.
7
Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery.
Int Immunopharmacol. 2003 Nov;3(12):1589-600. doi: 10.1016/S1567-5769(03)00181-4.
8
Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development.
BMC Infect Dis. 2011 Jan 26;11:26. doi: 10.1186/1471-2334-11-26.
9
Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
Int Immunopharmacol. 2004 Jan;4(1):1-14. doi: 10.1016/j.intimp.2003.09.001.
10
Immunological cytokine correlates of protective immunity and pathogenesis in leprosy.
Scand J Immunol. 2000 Apr;51(4):419-28. doi: 10.1046/j.1365-3083.2000.00703.x.

引用本文的文献

1
Modulation of the Response to and Pathogenesis of Leprosy.
Front Microbiol. 2022 Jun 2;13:918009. doi: 10.3389/fmicb.2022.918009. eCollection 2022.
2
New insights into the pathogenesis of leprosy: contribution of subversion of host cell metabolism to bacterial persistence, disease progression, and transmission.
F1000Res. 2020 Jan 31;9. doi: 10.12688/f1000research.21383.1. eCollection 2020.
3
Host Lipid Mediators in Leprosy: The Hypothesized Contributions to Pathogenesis.
Front Immunol. 2018 Feb 2;9:134. doi: 10.3389/fimmu.2018.00134. eCollection 2018.
4
Pathogen-specific epitopes as epidemiological tools for defining the magnitude of Mycobacterium leprae transmission in areas endemic for leprosy.
PLoS Negl Trop Dis. 2012;6(4):e1616. doi: 10.1371/journal.pntd.0001616. Epub 2012 Apr 24.
5
Lessons of leprosy: the emergence of TH17 cytokines during type II reactions (ENL) is teaching us about T-cell plasticity.
J Drugs Dermatol. 2012 May;11(5):626-30.
6
Immunoregulatory biological response modifiers: effect of cytokines on septic shock.
Mediators Inflamm. 1993;2(7):S5-S10. doi: 10.1155/S0962935193000675.
7
Immunological responses in patients with tuberculosis and in vivo effects of acetyl-L-carnitine oral administration.
Mediators Inflamm. 1993;2(7):S17-20. doi: 10.1155/S0962935193000699.
8
The continuing challenges of leprosy.
Clin Microbiol Rev. 2006 Apr;19(2):338-81. doi: 10.1128/CMR.19.2.338-381.2006.
9
Use of a whole blood assay to evaluate in vitro T cell responses to new leprosy skin test antigens in leprosy patients and healthy subjects.
Clin Exp Immunol. 1999 May;116(2):263-9. doi: 10.1046/j.1365-2249.1999.00892.x.
10
Quantitative assessment of tuftsin receptor expression and second messenger during in vitro differentiation of peripheral blood derived monocytes of leprosy patients.
Mol Cell Biochem. 1997 Jun;171(1-2):1-10. doi: 10.1023/a:1006861509742.

本文引用的文献

1
The immunology of leprosy: speculations on the leprosy spectrum.
Rev Infect Dis. 1981 May-Jun;3(3):422-69. doi: 10.1093/clinids/3.3.422.
2
Purification of murine T cell growth factor. A lymphocyte mitogen with helper activity.
J Exp Med. 1981 Aug 1;154(2):422-31. doi: 10.1084/jem.154.2.422.
3
Trypanosoma cruzi: induction of microbicidal activity in human mononuclear phagocytes.
J Immunol. 1982 May;128(5):2142-6.
4
T-cell conditioned media reverse T-cell unresponsiveness in lepromatous leprosy.
Nature. 1983 May 26;303(5915):342-4. doi: 10.1038/303342a0.
5
T cell-specific suppressor factor(s) with regulatory influence on interleukin 2 production and function.
J Immunol. 1982 Feb;128(2):784-90.
6
Studies on induction and effector functions of concanavalin A-induced suppressor cells that limit TCGF production.
J Immunol. 1982 Feb;128(2):746-50.
7
Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.
J Exp Med. 1983 Sep 1;158(3):670-89. doi: 10.1084/jem.158.3.670.
8
Macrophage activation: priming activity from a T-cell hybridoma is attributable to interferon-gamma.
Proc Natl Acad Sci U S A. 1983 Jun;80(12):3782-6. doi: 10.1073/pnas.80.12.3782.
9
Dendritic cells induce T lymphocytes to release B cell-stimulating factors by an interleukin 2-dependent mechanism.
J Exp Med. 1983 Dec 1;158(6):2040-57. doi: 10.1084/jem.158.6.2040.
10
The cutaneous infiltrates of leprosy: cellular characteristics and the predominant T-cell phenotypes.
N Engl J Med. 1982 Dec 23;307(26):1593-7. doi: 10.1056/NEJM198212233072601.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验